Changes in use of 17-OHPC after the PROLONG trial: a physician survey.

Futterman, Itamar D; Gilroy, Laura; Zayat, Nawras; Balhotra, Kimen; Weedon, Jeremy; Minkoff, Howard

Futterman, Itamar D; Gilroy, Laura; Zayat, Nawras; Balhotra, Kimen; Weedon, Jeremy; Minkoff, Howard.

Afiliación

Futterman ID; Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Maimonides Medical Center, Brooklyn, NY, USA.
Gilroy L; Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Maimonides Medical Center, Brooklyn, NY, USA.
Zayat N; Department of Obstetrics and Gynecology, State University of New York, Brooklyn, NY, USA.
Balhotra K; Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Maimonides Medical Center, Brooklyn, NY, USA.
Weedon J; Department of Epidemiology & Biostatistics, State University of New York, Brooklyn, NY, USA.
Minkoff H; Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Maimonides Medical Center, Brooklyn, NY, USA.

J Perinat Med ; 51(8): 1013-1018, 2023 Oct 26.

Article en En | MEDLINE | ID: mdl-37192539

Palabras clave

IM progesterone; physician survey; preterm birth; progesterone; vaginal progesterone

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: J Perinat Med Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Alemania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google